NEPT News Alert Neptune Technologies & Bioresources Inc (NEPT)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Neptune Technologies & Bioresources Inc (NEPT) 1.88 $NEPT

Doug Loe: Canada Has Earned Its Spot In The Biotech All-Star Team Photo
Life Sciences Report - Seeking Alpha - Fri Dec 19, 9:53AM CST
Biotech investors in the United States who overlook investment opportunities across the borders are missing out on huge opportunities, says Douglas Loe, healthcare equity analyst with Euro Pacific Canada. In this interview with The Life Sciences...
BIIB: 340.89 (+5.13), VRX: 140.33 (-0.22), QLTI: 3.72 (+0.08), CTRX: 51.83 (+0.14), BCRX: 11.83 (+0.76), ACT: 254.20 (-1.68), MDT: 74.08 (+0.31), TKMR: 13.97 (+0.14), NEPT: 1.88 (+0.03), BSX: 13.13 (+0.07), AGN: 210.12 (+0.95), CMRX: 36.80 (+0.70), ALNY: 93.52 (+0.97), SRPT: 13.88 (+0.47), SHPG: 209.29 (+0.07), NLNK: 39.08 (+1.36), SNY: 46.35 (+0.50), MSLI: 1.67 (+0.02), NVCN: 6.60 (unch), CRME: 8.56 (+0.06), EBS: 27.64 (+1.28), GSK: 42.85 (+0.11), CELG: 109.60 (+3.48), GILD: 91.29 (+1.84), MRK: 57.46 (+0.25), NVDQ: 16.90 (+0.55), NVS: 93.91 (+0.66)

Rolling With Biotech's Regulatory Punches: Chen Lin
Life Sciences Report - Seeking Alpha - Tue Nov 25, 3:36PM CST
Being temporarily burned by the U.S. Food and Drug Administration can be a mixed blessing for a biotech with a good product in the pipeline. In an interview with The Life Sciences Report , Chen Lin, publisher of the investor newsletter What is...
ACRX: 6.61 (+0.06), BMRN: 88.18 (+0.89), RNA: 18.76 (+0.10), SRPT: 13.88 (+0.47), MRK: 57.46 (+0.25), NLNK: 39.08 (+1.36), GSK: 42.85 (+0.11), SRNE: 9.50 (+0.99), NEPT: 1.88 (+0.03), CELG: 109.60 (+3.48)

New Chief at Neptune
Seeking Alpha - at Seeking Alpha - Mon Nov 24, 6:38AM CST

NEPT: 1.88 (+0.03)

Jim Hamilton Appointed President & CEO of Neptune
GlobeNewswire - Fri Nov 21, 7:07AM CST
Neptune Technologies & Bioressources Inc. ("Neptune" or the "Corporation" (Nasdaq:NEPT) (TSX:NTB), announces that its Board of Directors has appointed Jim Hamilton as President and Chief Executive Officer of Neptune and a member of the Board, effective February 2, 2015.
NTB.TO: 2.20 (+0.05), NEPT: 1.88 (+0.03)

9 Insiders Purchase Shares Of Neptune On The Open Market
D. Mero - Seeking Alpha - Tue Nov 18, 1:37PM CST
After the market closed on Friday, November 14th, Canadian Insider disclosed that 9 insiders purchased shares of Neptune Technologies (NASDAQ: NEPT ) in the open market during the past week, including the company's interim CEO, Andre Godin, and new...
NEPT: 1.88 (+0.03)

Neptune Completes Plant Ramp-Up
GlobeNewswire - Wed Nov 05, 7:07AM CST
Neptune Technologies & Bioressources Inc. ("Neptune" or the "Corporation" (Nasdaq:NEPT) (TSX:NTB), announces that its Sherbrooke plant ramp-up is successfully completed, with the plant now operating at an annualized production capacity of 150 metric tons.
NTB.TO: 2.20 (+0.05), NEPT: 1.88 (+0.03)

Neptune Receives TSX Approval for Normal Course Issuer Bid
GlobeNewswire - Thu Oct 30, 7:01AM CDT
Neptune Technologies & Bioressources Inc. ("Neptune" or the "Corporation" (Nasdaq:NEPT) (TSX:NTB) announces that it has received approval of the Toronto Stock Exchange (''TSX'' to proceed with its normal course issuer bid ("NCIB" announced on October 15, 2014.
NTB.TO: 2.20 (+0.05), NEPT: 1.88 (+0.03)

Neptune and BlueOcean Sign Licensing Agreement
GlobeNewswire - Mon Oct 20, 7:00AM CDT
Neptune Technologies & Bioressources Inc. ("Neptune" (Nasdaq:NEPT) (TSX:NTB), announces the signing of an exclusive world-wide, royalty-bearing, non-transferable, License Agreement ("License" with BlueOcean Nutrascience Inc. ("BlueOcean" under Neptune's composition and extraction patents covering the production and sale of marine derived oil products containing phospholipids. The License allows BlueOcean and its shrimp joint venture affiliate to produce and sell shrimp oil products extracted from three species of North Atlantic cold water shrimp (Pandalus borealis, Pandalus montagui, and Pandalus jordani) in the nutraceutical, dietary ingredients, natural health products, functional food and food supplements markets. The medical food, drugs and drug product markets are not included.
NTB.TO: 2.20 (+0.05), NEPT: 1.88 (+0.03)

Neptune Announces Normal Course Issuer Bid
GlobeNewswire - Wed Oct 15, 6:29AM CDT
Neptune Technologies & Bioressources Inc. ("Neptune" or the "Corporation" (Nasdaq:NEPT) (TSX:NTB) announces its intention to repurchase parts of its class A common shares (the "common shares" issued and outstanding by way of a normal course issuer bid ("NCIB" to be carried out by TD Securities Inc. through the facilities of the Toronto Stock Exchange ("TSX" and Nasdaq Stock Market ("Nasdaq" , in accordance with applicable Canadian and U.S. regulatory requirements and TSX rules, based on which Neptune may be allowed to repurchase up to the higher of 5% of its common shares issued and outstanding or 10% of its Public Float (as such term is defined under the TSX Policies).
NTB.TO: 2.20 (+0.05), NEPT: 1.88 (+0.03)

Investors look to Lighten Up on Shares of Neptune Technologies & Bioressources-Ord, Shares Down 18.8% (NEPT)
Comtex SmarTrend(R) - Tue Oct 14, 10:37AM CDT
Neptune Technologies & Bioressources-Ord (AMEX:NEPT) is one of today's worst performing low-priced stocks, down 18.8% to $1.27 on 1.2x average daily volume. Neptune Technologies & Bioressources-Ord has traded 335,000 shares thus far today, vs. average volume of 274,000 shares per day. The stock has underperformed the Dow (-19.1% to the Dow's 0.6%) and underperformed the S&P 500 (-19.1% to the S&P's 0.8%) during today's trading.
NEPT: 1.88 (+0.03)

Neptune Announces Second Quarter Results
GlobeNewswire - Tue Oct 14, 6:52AM CDT
Neptune Technologies & Bioressources Inc. ("Neptune" or the "Corporation" (Nasdaq:NEPT) (TSX:NTB), announces its consolidated financial results for the three and six months ended August 31, 2014.
NTB.TO: 2.20 (+0.05), NEPT: 1.88 (+0.03)

Neptune to Hold Conference Call to Discuss Second Quarter Results
GlobeNewswire - Wed Oct 08, 7:35AM CDT
Neptune Technologies & Bioressources Inc. ("Neptune" or the "Corporation" (Nasdaq:NEPT) (TSX:NTB), announced today that it will be holding a conference call on Wednesday October 15 at 9:00 AM (ET) to present its results for the second quarter ended August 31, 2014.
NTB.TO: 2.20 (+0.05), NEPT: 1.88 (+0.03)

IGOV, ISHG, NEPT, HCCI, COW, DDG Are Seasonally Ripe To Go Down In the Next Five Weeks
M2 - Wed Oct 08, 3:35AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Ishares S&P/Citigroup International Treasury Bond Fund (NASDAQ:IGOV), iShares S&P Citigroup 1-3 Year International Treasury Bond F (NASDAQ:ISHG), Neptun SA (NASDAQ:NEPT), Heritage-Crystal Clean Inc (NASDAQ:HCCI), iShares Global Agriculture Index (NYSE:COW), ProShares Short Oil & Gas (NYSE DG) and each have a high seasonal probability to go Down in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
DDG: 25.70 (+0.23), COW: 29.79 (-0.06), HCCI: 11.76 (-0.41), IGOV: 96.41 (+0.42), NEPT: 1.88 (+0.03), ISHG: 84.45 (+0.12)

Neptune Technologies & Bioressources-Ord Down 5.8%, Shares Slide into the Red (NEPT)
Comtex SmarTrend(R) - Thu Oct 02, 11:36AM CDT
Neptune Technologies & Bioressources-Ord (AMEX:NEPT) is one of today's worst performing low-priced stocks, down 5.8% to $1.63 on 1.9x average daily volume. Thus far today, Neptune Technologies & Bioressources-Ord has traded 432,000 shares, vs. average volume of 223,000 shares per day. The stock has underperformed the Dow (-5.8% to the Dow's -0.4%) and underperformed the S&P 500 (-5.8% to the S&P's -0.6%) during today's trading.
NEPT: 1.88 (+0.03)

Neptune Reaches Annualized Production Capacity of 100 Metric Tons
GlobeNewswire - Tue Sep 23, 7:08AM CDT
Neptune Technologies & Bioressources Inc. ("Neptune" or the "Corporation" (Nasdaq:NEPT) (TSX:NTB), announces that its Sherbrooke plant is now operating at an annualized production capacity of 100 metric tons and customer shipments of Neptune manufactured krill oil products have commenced.
NTB.TO: 2.20 (+0.05), NEPT: 1.88 (+0.03)

Neptune to Present at Rodman & Renshaw Global Investment Conference
GlobeNewswire - Wed Sep 03, 7:08AM CDT
Neptune Technologies & Bioressources Inc. ("Neptune" or the "Company" (Nasdaq:NEPT) (TSX:NTB) announced today that Andre Godin, Neptune's Interim President and Chief Executive Officer, will present at the upcoming Rodman & Renshaw 16 Annual Global Investment Conference on Wednesday, September 10, 2014 at 10:00 a.m. Eastern Time. The Conference is being held at the New York Palace Hotel in New York City.
NTB.TO: 2.20 (+0.05), NEPT: 1.88 (+0.03)

Neptune's Production Ramp-Up on Target
GlobeNewswire - Thu Aug 14, 7:01AM CDT
Neptune Technologies & Bioressources Inc. ("Neptune" or the "Corporation" (Nasdaq:NEPT) (TSX:NTB), announces that its Sherbrooke plant is now operating at an annualized production capacity of 50 metric tons.
NTB.TO: 2.20 (+0.05), NEPT: 1.88 (+0.03)

Why Neptune Technologies (NEPT) Could Be Positioned for a Slump - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Jul 30, 7:42AM CDT
Neptune Technologies has witnessed a significant price decline in the past four weeks and negative earnings estimate revisions for the current quarter and the current year, making it time for investors to sell it off.
ENDP: 72.10 (+0.34), UTHR: 130.22 (+2.40), SLXP: 114.92 (-1.18), NEPT: 1.88 (+0.03)

Neptune Announces First Quarter Results
GlobeNewswire - Wed Jul 16, 3:53AM CDT
Neptune Technologies & Bioressources Inc. ("Neptune" or the "Corporation" (Nasdaq:NEPT) (TSX:NTB), announces its consolidated financial results for the first quarter ended May 31, 2014.
NTB.TO: 2.20 (+0.05), NEPT: 1.88 (+0.03)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

ECW Puts $52 Million Behind Learning Through Crisis

Updated Category News Views 66

A reserve fund for a classroom is not glamorous, but it may be the smartest detail in this whole $52 million commitment. Education Cannot Wait has announced support for more than 300,000 children in Lebanon, Myanmar and South Sudan, where war, flooding and displacement have ripped ordinary schooling apart. The money is meant to restore learning, provide catch-up classes...

Continue Reading
Kyverna Probe Reopens IPO Disclosure Questions for Investors

Updated Category News Views 22

Clinical-trial caveats have a nasty habit of becoming shareholder headaches years later. Kyverna Therapeutics is back in that uncomfortable zone after Kahn Swick & Foti said it has opened an investigation into whether the company’s officers and directors breached fiduciary duties or otherwise violated state or federal law. For holders of KYTX, this is not a verdict and...

Continue Reading
YYForce Security Win Adds Recurring Singapore Revenue Base

Updated Category News Views 160

A retail-property security mandate rarely makes anyone pound the table, and frankly it should not. Still, YYForce has landed a tangible two-year contract in Singapore worth roughly S$831,120, with subsidiary Uniforce Security Services set to begin work on December 1, 2026. For NASDAQ:YFOR investors, this is the kind of small, operationally real win that deserves a sober...

Continue Reading
ASA’s 2026 Grants Push Dermatology Into New Terrain

Updated Category News Views 58

Thirteen Small Bets With Serious Human Stakes Skin science rarely gets the splashy headlines, yet it touches a staggering number of people and carries some very stubborn unanswered questions. American Skin Association’s 2026 grant class puts 13 awards across skin cancer and dermatologic disease, with a noticeable willingness to follow newer clinical terrain rather than...

Continue Reading
Niron's $1.8B Alabama Bet Carries Big Magnet Stakes

Updated Category News Views 54

A Huge Factory Claim Needs More Than Applause A magnet company just tossed a very large number onto Alabama's economic-development table. Niron Magnetics says it plans a $1.8 billion investment in the state that would create 700 jobs. That is not pocket change, not a ribbon-cutting trinket, and not the sort of announcement investors should breeze past between earnings...

Continue Reading
Appian Survey Flags AI Aloneware Maintenance Drag Risk

Updated Category News Views 58

A bot can spit out a feature before lunch, then leave a repair bill nobody budgeted for. That is the uncomfortable issue behind Appian's new research on AI-assisted software development: speed is easy to celebrate, while ownership gets shoved into a dark corner until something breaks. Appian said on November 20, 2026, that two-thirds of surveyed AI decision-makers and IT...

Continue Reading
Sogroya Approval Broadens Novo's Pediatric Growth Franchise

Updated Category News Views 75

Seven fewer injections every week is the real headline behind Novo Nordisk's latest FDA clearance, not some flashy efficacy leap. On November 20, 2026, the company said Sogroya, its once-weekly long-acting growth hormone, won approval for children aged 2.5 and older with growth failure associated with Turner syndrome. That matters because treatment can stretch over years,...

Continue Reading
PCS Rental Prep Is About Control Before Distance Hits

Updated Category News Views 82

A vacant house can turn into a long-distance headache with startling speed. For military homeowners preparing for a PCS move, the useful point in Rhonda Leahy's guidance is not glamorous: settle the boring operational stuff before the moving boxes, travel orders, and new-duty-station chaos swallow the calendar. Renting out a former home is not merely collecting enough...

Continue Reading
Mobile Core's Cost Crunch Favors Telecom's Big Three

Updated Category News Views 67

Server bills have finally crashed the party in mobile core, and nobody should pretend that is a minor inconvenience. Dell'Oro Group's 3Q 2026 read is blunt: Mobile Core Network revenue growth was lackluster because 5G spending came in below expectations, while higher server costs pushed operators to reshuffle priorities, postpone projects, and keep 4G core gear alive...

Continue Reading
Why Brief Chiropractic Visits Still Need Clear Expectations

Updated Category News Views 76

A few minutes on the table can sound almost suspiciously brisk when somebody is dealing with a stiff neck, sore back, or nagging joint discomfort. Yet that is the central point in Dr. Craig Peterson's explanation for HelloNation: the adjustment itself may be brief, while the value of a chiropractor visit depends on a focused assessment, appropriate technique, and whether...

Continue Reading

Top 5 Most Recently Viewed Articles

Organon & Co. Class Action Lawsuit: Key Details You Should Know

Updated Category News Views 221

Overview of the Class Action Lawsuit Against Organon & Co. The latest developments in the class action lawsuit regarding Organon & Co. (NYSE: OGN) have attracted attention from investors. The lawsuit is aimed at representing purchasers of Organon's publicly traded securities during a specific time frame. Robbins Geller Rudman & Dowd LLP has taken the lead in filing this...

Continue Reading
JINRO Partners with BTS's V: A Strategic Move

Updated Category News Views 25

What's Brewing Between JINRO and BTS's V? Picture this: you're wandering the aisles of an international market, see a splashy new bottle of soju, and notice V from BTS smiling from the label. That's right, folks, JINRO, the world's reigning soju brand, has just snagged a partnership with BTS's V to serve up a global brand punch. This move isn't just a pretty face on a...

Continue Reading
Latin Metals Unveils Exciting Spin-Out Plan for Copper Assets

Updated Category News Views 172

Latin Metals Moves Forward with Spin-Out of Peruvian Assets Latin Metals Inc. (TSXV: LMS, OTCQB: LMSQF) is charting a new course by announcing its decision to spin-out certain Peruvian exploration projects into a newly founded subsidiary named Latin Explore. This strategic move aims to unlock value for shareholders while maintaining a robust exploration agenda. Overview...

Continue Reading
McCormick's Resilience Shines Amidst Economic Challenges

Updated Category News Views 66

McCormick Challenges and Growth Strategy McCormick & Company, Inc. (NASDAQ: MKC) recently announced its third-quarter earnings, revealing a solid financial performance, even in a tough consumer environment. The company achieved a 1% volume growth in its Consumer segment and steady sales in its Flavor Solutions segment, showcasing a strong market presence despite...

Continue Reading
Goodyear's Financial Performance Amidst Industry Challenges

Updated Category News Views 248

Understanding Goodyear's Recent Earnings Report Goodyear Tire & Rubber Co (NASDAQ: GT) has reported its recent financial results, particularly highlighting the challenges faced during the second quarter of their fiscal year 2025. This period proved to be quite turbulent after the closing bell, reflecting considerable disruptions in their operating environment that...

Continue Reading